Depressione e ansia: quale legame con la demenza?

Scritto da Elisa Di Rosa

Bibliografia

Barca, M. L., Eldholm, R. S., Persson, K., Bjørkløf, G. H., Borza, T., Telenius, E., ... & Engedal, K. (2019). Cortisol levels among older people with and without depression and dementia. International Psychogeriatrics, 31(4), 597-601.

Baxter, A. J., Scott, K. M., Ferrari, A. J., Norman, R. E., Vos, T., & Whiteford, H. A. (2014). Challenging the myth of an “epidemic” of common mental disorders: trends in the global prevalence of anxiety and depression between 1990 and 2010. Depression and anxiety, 31(6), 506-516.

Becker, E., Rios, C. L. O., Lahmann, C., Ruecker, G., Bauer, J., & Boeker, M. (2018). Anxiety as a risk factor of Alzheimer's disease and vascular dementia. The British Journal of Psychiatry, 213(5), 654-660.

Bennett, S., & Thomas, A. J. (2014). Depression and dementia: cause, consequence or coincidence?. Maturitas, 79(2), 184-190.

Byers, A. L., & Yaffe, K. (2011). Depression and risk of developing dementia. Nature Reviews Neurology, 7(6), 323-331.

Cantón-Habas, V., Rich-Ruiz, M., Romero-Saldaña, M., & Carrera-González, M. D. P. (2020). Depression as a risk factor for dementia and Alzheimer’s disease. Biomedicines, 8(11), 457.

COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021; 398: 1700-1712

Dafsari, F. S., & Jessen, F. (2020). Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease. Translational Psychiatry, 10(1), 160.

Daulatzai, M. A. (2017). Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease. Journal of neuroscience research, 95(4), 943-972.

Ettman, C. K., Cohen, G. H., Abdalla, S. M., Trinquart, L., Castrucci, B. C., Bork, R. H., ... & Galea, S. (2022). Assets, stressors, and symptoms of persistent depression over the first year of the COVID-19 pandemic. Science Advances, 8(9), eabm9737.

Gigantesco, A., Minardi, V., Contoli, B., & Masocco, M. (2022). Depressive symptoms among adults in 2018–2019 and during the 2020 COVID-19 pandemic in Italy. Journal of affective disorders, 309, 1-8.

Gimson, A., Schlosser, M., Huntley, J. D., & Marchant, N. L. (2018). Support for midlife anxiety diagnosis as an independent risk factor for dementia: a systematic review. BMJ open, 8(4), e019399.

Han, L. K., Aghajani, M., Clark, S. L., Chan, R. F., Hattab, M. W., Shabalin, A. A., ... & Penninx, B. W. (2018). Epigenetic aging in major depressive disorder. American Journal of Psychiatry, 175(8), 774-782.

Istituto Superiore di Sanità. Consensus Conference sulle terapie psicologiche per ansia e depressione. Documento finale. Gruppo di lavoro “Consensus sulle terapie psicologiche per ansia e depressione” 2022, x, 105 p. Consensus ISS 1/2022

Jamieson, A., Goodwill, A. M., Termine, M., Campbell, S., & Szoeke, C. (2019). Depression related cerebral pathology and its relationship with cognitive functioning: A systematic review. Journal of affective disorders, 250, 410-418.

Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018). Inflammation as a central mechanism in Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 4, 575-590.

Kuring, J. K., Mathias, J. L., & Ward, L. (2020). Risk of Dementia in persons who have previously experienced clinically-significant Depression, Anxiety, or PTSD: A Systematic Review and Meta-Analysis. Journal of Affective Disorders, 274, 247-261.

Lipson, S. K., Lattie, E. G., & Eisenberg, D. (2019).

Numero della rivista 24 2023